A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1992
03/25/1992	CN1059659A Diagnosis and treatment of viral hepatitis
03/25/1992	CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1
03/24/1992	US5099015 Trifluoromethyl 1-carba(1-dethia)cephems
03/24/1992	US5098927 Antiretroviral agent, method of use thereas, and method of preparation
03/24/1992	US5098923 Aromatase inhibiting 4(5)-imidazoles
03/24/1992	US5098912 Bactericides for grampositive bacteria
03/24/1992	CA1297789C Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
03/22/1992	WO1992005284A1 Compositions and methods for inhibiting growth or replication of viruses
03/22/1992	WO1992005266A2 Packaging cells
03/22/1992	CA2092711A1 Compositions and methods for inhibiting growth or replication of viruses
03/22/1992	CA2051829A1 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis
03/19/1992	WO1992004446A1 Cloning of chicken anaemia dna
03/19/1992	WO1992004375A1 Hrsv vaccine
03/19/1992	WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
03/19/1992	WO1992004353A1 Cephalosporin derivatives and their homologues
03/19/1992	WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods
03/18/1992	WO1992005191A1 Fungicidally active compounds
03/18/1992	WO1992005153A1 Antiproliferative substituted naphthalene compounds
03/18/1992	EP0475706A1 Novel squalene synthetase inhibitors
03/18/1992	EP0475664A1 Lubricant composition and use thereof
03/18/1992	EP0475577A1 Hydrogenated rapamycin derivatives
03/18/1992	EP0475478A1 Haemophilus paragallinarum vaccine
03/18/1992	EP0475231A1 Benzodiazepines
03/18/1992	EP0475150A1 Antibiotic C-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and use thereof
03/18/1992	EP0380584B1 Polyene macrolide pre-liposomal powders
03/18/1992	EP0188573B1 Dietary supplement for minimizing effects of infection
03/18/1992	CN1059528A Carbocyclic analogs of certain nucleosides
03/18/1992	CN1059471A Heamophilus paragallinarum vaccine
03/18/1992	CA2091905A1 Fungicidally active compounds
03/18/1992	CA2091688A1 Antiproliferative substituted naphthalene compounds
03/18/1992	CA2050823A1 Fungicidal compositions and method
03/18/1992	CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies
03/17/1992	US5096922 Sorangicin antibiotics
03/17/1992	US5096899 Oxapenem-3-carboxylic acids
03/17/1992	US5096888 Macrolactone antibiotics
03/17/1992	US5096886 Bacteriostats
03/17/1992	US5096708 Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
03/17/1992	CA1297478C 2,6-dideoxy-2-fluoro-l-talopyranose and derivatives thereof and the production of these compounds
03/17/1992	CA1297473C Crystallized cephem-acid addition salts, and a process for the preparation thereof
03/14/1992	CA2050739A1 Squalene synthetase inhibitors
03/13/1992	WO1992004444A1 Methods for producing acyloxyacyl hydrolase
03/13/1992	CA2091242A1 Methods for producing acyloxyacyl hydrolase
03/12/1992	WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man
03/12/1992	CA2091335A1 Antibodies for treatment and prevention of infection in animals and man
03/11/1992	EP0474597A2 Diphenyl compounds as inhibitors of the arachidonic acid pathway and their use in pharmaceutical compositions
03/11/1992	EP0474506A1 Antimicrobial peptides
03/11/1992	EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations
03/11/1992	EP0474243A1 1-Methylcarbapenem derivatives and process for preparation thereof
03/11/1992	EP0474049A1 Antibiotic C-3 catechol-substituted cephalosporin compounds, compositions and use thereof
03/11/1992	EP0474038A1 New 2-tert. substituted methyloxapenem-3-carboxylic acids and esters, their preparation and use
03/11/1992	EP0474013A1 Process for the preparation of crystalline TACS
03/11/1992	EP0473707A1 Injectable clarithromycin composition
03/11/1992	EP0473673A1 Method for protection from azt side effects and toxicity
03/11/1992	EP0422097A4 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
03/11/1992	CN1059277A Local drug delivery compositions for dental use
03/11/1992	CN1059276A Pharmaceutical composition of florfenicol
03/11/1992	CA2050858A1 Benzodiazepines
03/11/1992	CA2050358A1 Lubricant composition and use thereof
03/10/1992	US5095139 Fungicides
03/10/1992	US5095127 Process for producing polycyclic ether antibiotics
03/10/1992	US5095112 Process for the preparation of quinolonecarboxylic acid esters
03/10/1992	US5095013 Antibiotics
03/10/1992	US5095012 Bactericides
03/10/1992	US5095011 Antibiotics, cephalosporina
03/10/1992	US5095005 For foods
03/10/1992	CA1297110C 2-aza-substituted 1-carbadethiapen-2-em-3-carboxylic acids
03/10/1992	CA1297055C Method for selectively increasing the ratio of single major components ofantibiotic a/40926 complex
03/10/1992	CA1297032C Use of avarone and avarol and derivatives thereof for the control of aidsand arc
03/10/1992	CA1297027C Vaginal suppository
03/10/1992	CA1297006C Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
03/08/1992	WO1992004328A1 Antiviral compounds and antihypertensive compounds
03/08/1992	WO1992004327A1 Antiviral compounds and antihypertensive compounds
03/08/1992	WO1992004326A1 Antiviral compounds
03/08/1992	CA2091173A1 Antiviral compounds and antihypertensive compounds
03/08/1992	CA2091171A1 Antiviral compounds
03/08/1992	CA2050850A1 Recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process
03/06/1992	CA2050402A1 Medicaments containing substituted 2-cyclohexene derivatives and their use for the control of diseases
03/06/1992	CA2049129A1 Haemophilus paragallinarum vaccine
03/05/1992	WO1992004061A1 Antimicrobial preservation of plasma
03/05/1992	WO1992004031A1 Preservation of blood, tissues and biological fluids
03/05/1992	WO1992003568A1 Sugar modified oligonucleotides that detect and modulate gene expression
03/05/1992	WO1992003566A1 Therapeutic ribozyme compositions
03/05/1992	WO1992003545A1 Flavivirus recombinant poxvirus vaccine
03/05/1992	WO1992003535A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same
03/05/1992	WO1992003472A1 Peptides containing amino-polyols as transition-state mimics
03/05/1992	WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
03/05/1992	WO1992003457A1 Entamoeba histolytica immunodominant surface antigens
03/05/1992	WO1992003456A1 Oligonucleotides for modulating the effects of cytomegalovirus infections
03/05/1992	WO1992003444A1 Penem compounds
03/05/1992	WO1992003443A1 Antibacterial penem compounds
03/05/1992	WO1992003442A1 Antibacterial penem esters derivatives
03/05/1992	WO1992003437A1 10(1-hydroxyethyl)-11-oxo-1-azatricyclo[7.2.0.0.3.8]undec-2-ene-2-carboxylic acid esters and a process for preparing thereof
03/05/1992	WO1992003165A1 New use of a monoclonal antibody
03/05/1992	WO1992003162A1 Vaccines
03/05/1992	WO1992003157A1 Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
03/05/1992	WO1992003151A1 Uses of recombinant colony stimulating factor-1
03/05/1992	WO1992003147A1 Peptides that block human immunodeficiency virus infections and methods of use thereof
03/05/1992	WO1992003137A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
03/05/1992	WO1992003135A1 Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders
03/05/1992	WO1991015200A3 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases

1 ... 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 ... 1798